Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study.

Details

Language :

English

ISSN :

01676997

Volume :

29

Issue :

1

Database :

Complementary Index

Journal :

Investigational New Drugs

Publication Type :

Academic Journal

Accession number :

56940187

Full Text :

https://doi.org/10.1007/s10637-009-9307-8